Ithaca, NY, United States of America

Doug Cordeau



 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Foster City, CA (US) (2013)
  • Ithaca, NY (US) (2014 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: An Insight into the Innovations of Doug Cordeau

Introduction

Doug Cordeau, based in Ithaca, NY, is a prominent inventor specializing in pharmaceutical agents. With a remarkable portfolio of three patents, Cordeau has made significant contributions to the field of medicinal chemistry through innovative processes and compounds.

Latest Patents

Among his latest innovations, Cordeau has developed methods and intermediates for preparing pharmaceutical agents that are particularly aimed at synthesizing a compound of formula I and its various salts. This invention is crucial for the creation of effective medicinal compounds, demonstrating his commitment to advancing pharmaceutical science.

Career Highlights

Currently, Doug Cordeau is associated with Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovative health solutions. His role within the organization allows him to leverage his expertise in pharmaceuticals while driving impactful research projects that could lead to groundbreaking treatments.

Collaborations

Throughout his career, Cordeau has collaborated with notable colleagues such as Richard P. Polniaszek and Steven S. Pfeiffer. These collaborations not only enhance the breadth of research outcomes but also contribute to a dynamic work environment that fosters innovation.

Conclusion

Doug Cordeau's contributions to pharmaceutical inventions are a testament to his ingenuity and dedication to medical science. His patents represent important advancements that hold the potential for significant impact in healthcare. As he continues his work at Gilead Sciences, the pharmaceutical community eagerly anticipates the outcomes of his innovative approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…